Metoclopramide on Gastric Emptying in Mechanically Ventilated Patients
NCT05641051 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2023-06-22
Summary
The aim of this study is to evaluate the prokinetic effect of metoclopramide on gastric emptying in critically ill mechanically ventilated patients .
Conditions
- Gastric Emptying
- Mechanically Ventilation
- Randomized Controlled Trial
- Metoclopramide
Interventions
- DRUG
-
Metoclopramide
Cases will receive 10 mg intravenous metoclopramide every 6 hours.
- DRUG
-
Cases will receive the same volume of IV placebo / 6 hours.
Sponsors & Collaborators
-
Tanta University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-14
- Primary Completion
- 2023-06-16
- Completion
- 2023-06-16
Countries
- Egypt
Study Locations
More Related Trials
-
Efficacy of Itopride Versus Metoclopramide in Hospitalized Medicine Patients With High Gastric Residual Volume
NCT07031479 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Washed Microbiota Transplantation for Diabetic Gastroparesis
NCT06340217 ·Status: RECRUITING ·Phase: NA
-
Reletex Versus Standard of Care Therapy for Post-Operative Nausea Control in Patients Undergoing Foregut Surgery
NCT01510379 ·Status: COMPLETED ·Phase: NA
-
Effect of Dexmedetomidine on Gastric Emptying and Gastrointestinal Transit
NCT01084473 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Ondansetron Dose and Timing on Post-operative Nausea and Vomiting
NCT03297021 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Single Doses of GSK962040 in Critically Ill Patients With Enteral Feed Intolerance
NCT01039805 ·Status: COMPLETED ·Phase: PHASE2
-
Nutritional Adequacy Therapeutic Enhancement in the Critically Ill. The NUTRIATE Study
NCT01934192 ·Status: TERMINATED ·Phase: PHASE2
-
A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Single Dose of Intravenous TD-8954 Compared With Metoclopramide in Critically Ill Patients With Enteral Feeding Intolerance
NCT01953081 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Usefulness of Metoclopramide to Improve Endoscopic Visualization in Upper Gastrointestinal Bleeding
NCT06297954 ·Status: COMPLETED ·Phase: PHASE3
-
Metoclopramide vs Placebo for Prevention of Pneumonia in Acute Stroke
NCT04873297 ·Status: COMPLETED ·Phase: PHASE4
-
Ondansetron Versus Metoclopramide in Treatment of Vomiting in Gastroenteritis
NCT01165866 ·Status: COMPLETED ·Phase: PHASE4
-
Broadening Antiemetics Research by Comparing the Effectiveness of Fosaprepitant and Metoclopramide
NCT06740812 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
A Study to Evaluate Safety, Side Effects, Muscle Activity and Speed of Gastric Emptying of GSK962040
NCT00562848 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects.
NCT00733551 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Methylnaltrexone on GI Transit in Healthy Volunteers
NCT01055704 ·Status: COMPLETED ·Phase: PHASE4
-
Washed Microbiota Transplantation Alleviates Diabetic Gastrointestinal Motility Disorders: an Efficacy and Safety Study
NCT06340828 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Prokinetic Drugs and Enteral Nutrition
NCT00916591 ·Status: UNKNOWN
-
Comparison of Ondansetron, Metoclopramide and Promethazine for the Treatment of Nausea and Vomiting in the Adult ED
NCT00655642 ·Status: TERMINATED ·Phase: NA
-
Efficacy of Three Antiemetics in Preventing Nausea and Vomiting
NCT05533281 ·Status: COMPLETED ·Phase: PHASE4
-
Metoclopramide in Upper Gastrointestinal Bleed
NCT05746377 ·Status: UNKNOWN ·Phase: PHASE4
-
Intravenous Haloperidol Versus Ondansetron for Treatment of Established Post-operative Nausea and Vomiting
NCT02143531 ·Status: COMPLETED ·Phase: PHASE4
-
Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic Gastroparesis
NCT02025751 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter, Randomized, Controlled Trial of SCH 619734 for the Treatment of Chemotherapy-Induced Nausea and Vomiting (Study P04351AM2)(COMPLETED)
NCT00394966 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Meclizine Orodispersible Tablet Pharmacokinetic in Human Volunteers
NCT04564144 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Uncomplicated Nausea and Vomiting in the Emergency Department
NCT00778011 ·Status: COMPLETED ·Phase: PHASE4